Resolution of inflammation in xenobiotic-induced mucosal injury and chronic disease

Kymberly M Gowdy1, Debra L Laskin2

  • 1Pulmonary, Critical Care and Sleep Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States.

Insights

Toxicant exposure can impair the body's natural inflammation resolution processes, leading to chronic diseases. Understanding these mechanisms reveals new therapeutic targets for toxicant-induced pathologies.

Area of Science:

  • Toxicology
  • Immunology
  • Pathology

Background:

  • Toxicants are known to cause injury and inflammation across organ systems.
  • Emerging research highlights toxicants' role in chronic diseases by disrupting inflammation resolution.
  • Inflammation resolution involves complex pathways crucial for returning tissue to homeostasis.

Discussion:

  • Toxicant exposure can impede critical resolution processes like mediator catabolism and efferocytosis.
  • Impaired resolution pathways contribute to the development and persistence of chronic inflammatory diseases.
  • This special issue focuses on the detrimental effects of toxicants on inflammation resolution.

Key Insights:

  • Toxicants disrupt the dynamic biological mechanisms that actively resolve inflammation.
  • Understanding how toxicants interfere with resolution pathways is key to preventing chronic pathologies.
  • Identifying specific molecular targets affected by toxicants offers therapeutic potential.

Outlook:

  • Further research is needed to elucidate the precise mechanisms of toxicant-induced resolution impairment.
  • Developing therapies that restore resolution pathways could mitigate toxicant-induced chronic diseases.
  • This field holds promise for novel strategies in managing inflammatory conditions caused by environmental exposures.

Related Concept Videos

Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
3.5K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
167
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
512
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
330
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
202
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
127